Verrica Pharmaceuticals Inc. (VRCA) Total liabilities 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) total liabilities at each fiscal year-end, per SEC filings.
$22.4MFY2025 · since FY2021: $47.5M → $22.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.4M | -65.0% |
| FY2024 | $64.0M | +3.5% |
| FY2023 | $61.8M | +1219.0% |
| FY2022 | $4.7M | -90.1% |
| FY2021 | $47.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating marginVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Shareholders’ equityVRCA overview →